logo
  

Cortexyme Announces Completion Of Novosteo Acquisition

Biopharmaceutical company Cortexyme, Inc. (CRTX) announced Friday the completion of its acquisition of privately-held biotech company Novosteo, which targets therapeutics to treat rare skeletal diseases, bone cancer and injury. Novosteo stockholders now own approximately 15.5% of the combined company.

With the completion of the acquisition, Cortexyme appointed former Novosteo executives Dr. Dirk Thye as Chief Executive Officer, and Dr. Karen Smith as Chief Medical Officer of Cortexyme. Dr. Thye and Dr. Philip Low have also been appointed to the Cortexyme's Board of Directors.

Cortexyme plans to change its name to Quince Therapeutics, Inc. and begin trading under the ticker symbol "QNCX" in the coming months, to reflect the broadening pipeline of the company.

In conjunction with the close of the Novosteo acquisition, Cortexyme reported that the Compensation Committee of the company's Board of Directors approved grants of stock options to purchase an aggregate of 3,744,255 shares of Cortexyme's common stock.

The stock options are being issued as an inducement material to each new employee entering into employment with Cortexyme.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The Federal Communications Commission or FCC has granted SpaceX Services, Inc. authorization to use its Starlink satellite internet system on vehicles in motion. SpaceX, owned by Elon Musk, is allowed to operate consumer and enterprise Ku-band Earth Stations in Motion or ESIM using frequencies allocated to the fixed satellite service. The approval would help the company to expand its services to Loud Muscle Science, LLC is recalling certain Launch Sequence products in the United States and Canada citing the presence of undeclared Tadalafil, the U.S. Food and Drug Administration said. These tainted Launch Sequence Capsule products are marketed as dietary supplements for male sexual enhancement. The U.S. Food and Drug Administration announced the intended availability of around 17 million bottles equivalent of general infant formula to be imported from New Zealand and Ireland. Under the FDA's enforcement discretion to source more infant formula to the U.S., French food company Danone SA will send 555,000 cans Aptamil Gold Plus from New Zealand.
RELATED NEWS
Follow RTT